P-MAM: Effects of Prebiotics on Metagenomic Diversity and Abundance in Young Children With Acute Malnutrition

Sponsor
University of the Punjab (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06155474
Collaborator
University of Veterinary and Animal Sciences, Lahore - Pakistan (Other)
200
1
3
5
40

Study Details

Study Description

Brief Summary

Malnutrition is a major global public health issue, contributing to poor health and early morbidities in children under five, particularly in developing countries. In 2021, 5 million children died worldwide due to infectious diseases or malnutrition, with Pakistan having the highest under-five mortality rate. With a population of approximately 229 million, Pakistan is the fifth most populous country in the world. In Pakistan, under-five mortality is 63.3 per 1000 live births which has declined from 139.8 in 1990 to 63.3 in 2021 (WHO, 2022, UNICEF, 2023). The monsoon season's massive flooding in Pakistan has worsened the humanitarian situation, endangering the already vulnerable population. UNICEF reports high rates of acute malnutrition, political instability, economic decline, and coronavirus disease 2019 effects. However, there is limited evidence on the efficacy of probiotics for infants in Pakistan.

Metagenomics is the study of microorganisms' genomes, examining all microorganisms in an ecological site's genomes. It involves extracting and sequencing DNA using high-throughput techniques. Scientists can identify genes with significant features using computer analysis. The distal intestine contains around one trillion organisms per milliliter of luminal contents, and understanding their potential for energy and nutrient harvest is crucial in malnourished individuals.

Alpha diversity is the analysis of species diversity in a sample, measured by observed species index, Chao1 index, Shannon index, Simpson index, and good-coverage index. It is proportional to the first four values and indicates less undiscovered species. The distal intestine contains around one trillion organisms per milliliter of luminal contents, with an increased capacity for energy harvest in malnourished individuals.

The present study aims to measure the following objectives. i. -To estimate the microbiome degree of diversity among malnutrition children micro-biota defined by 16 Svedberg (S) ribosomal ribonucleic acid gene sequencing.

  1. -To evaluate the interpersonal differences in the structure and functioning of the gut microbiome that affect a person's vulnerability to malnutrition.

  2. -To determine how microbiomes are shaped by host genotypes, environmental exposures, including exposure to malnutrition in children mothers, and other family members, nutritional status, and lifestyles, including diet.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Prebiotic galacto-oligosaccharide (GOS) Powder
  • Dietary Supplement: Starch Only
  • Dietary Supplement: RUTF + Starch
N/A

Detailed Description

Metagenomics is the study of microorganisms' genomes through the direct extraction and cloning of their DNA from a collection of microorganisms, also known as environmental and community genomics. The examination of all the microorganisms in an ecological site's genomes, the majority of which cannot be produced under standard laboratory conditions, is called metagenomics. In order to achieve this, the site's microbial population must first be removed, and then its DNA must be isolated and sequenced using high-throughput techniques. Scientists may identify genes with significant features, such as virulence genes or genes encoding enzymes of commercial significance, using computer analysis of a sequence.

Around one trillion organisms per milliliter of luminal contents are found in the distal intestine, where the majority of these bacteria are found. It is essential to describe the microbiota and its microbiome in malnourished persons and to define their potential to harvest energy and nutrients in light of the discovery that the intestinal microbiota/ microbiome linked with obesity has an increased capacity for energy harvest.

Deficiency of iron has been recognized in malnourished children. Iron present in RUTF is not sufficient to elevate "circulating levels of ferritin into the optimal physiological range. Prebiotics has been proven to have anti-inflammatory and antimicrobial actions that might enhance response to standard therapy for severe acute malnutrition (SAM), Targeting the gut microbiota through the use of Prebiotics as part of treatment in malnourished children may present an affordable and cost-effective strategy in the prevention and also in the treatment Fortifying the microbiota with Prebiotics could enhance energy and may protect against diarrhoea. However, randomized controlled trials evaluating the effects of prebiotic supplementation in children with severe acute malnutrition have not previously been done. So clinical evidence is lacking and cannot be translated into clinical practice.

Content of "Ready-to-use therapeutic food" may not be optimal to support weight gain a in children with severe acute malnutrition. Further trials are required to conclude whether Prebiotics containing Galactooligosaccharides supplement can improve weight gain in children with severe acute malnutrition in other settings.

Trial Objectives and Endpoints Trial Objectives

  • To estimate the microbiome degree of diversity among malnutrition children micro-biota defined by 16 Svedberg (S) ribosomal ribonucleic acid gene sequencing.

  • To evaluate the interpersonal differences in the structure and functioning of the gut microbiome that affect a person's vulnerability to malnutrition.

  • To determine how microbiomes are shaped by host genotypes, environmental exposures, including exposure to malnutrition in children mothers, and other family members, nutritional status, and lifestyles, including diet.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
PrebioticPrebiotic
Masking:
Double (Participant, Investigator)
Masking Description:
During trial conduct, the following groups will all be blinded to participants' allocation Healthy/Control, Malnutrition (RUTF) and Malnutrition (RTUF + prebiotics)
Primary Purpose:
Treatment
Official Title:
Effects of Prebiotics on Metagenomic Diversity and Abundance in Young Children With Acute Malnutrition: A Double-blinded Randomised Controlled Trial (PMAM)
Anticipated Study Start Date :
Jan 1, 2024
Anticipated Primary Completion Date :
Mar 1, 2024
Anticipated Study Completion Date :
Jun 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Healthy/Control (Starch)

The Healthy Controls will be given starch packed in the same way as the active prebiotics

Dietary Supplement: Starch Only
The Starch Solution is a low-fat diet.

Experimental: Malnutrition (RUTF + Starch)

The Malnutrition group with RUTF and Starch only. The RUTF will be given as per the WHO guidelines

Dietary Supplement: RUTF + Starch
ready-to-use therapeutic food and The Starch Solution is a low-fat diet.

Active Comparator: Malnutrition (RUTF + prebiotics)

The Malnutrition group with RUTF and Prebiotic only. The RUTF will be given as per the WHO guidelines

Dietary Supplement: Prebiotic galacto-oligosaccharide (GOS) Powder
Prebiotic GOS Powder is a galacto-oligosaccharide ingredient low in mono-sugars. Scientific studies have shown positive effects of oligosaccharides, among which galacto-oligosaccharides, on growth of bifidobacterial, stool consistency bowel function and transit time, support of natural defenses and mineral absorption. The product mainly consists of 97% dry matter with 69% prebiotic GOS, 23% lactose and 5% glucose and galactose as monosaccharides. These prebiotics have β-(4) glycosidic linkages and have been proven as safe product

Outcome Measures

Primary Outcome Measures

  1. Microbiome diversity [8 Weeks]

    Microbiome diversity examination among malnourished children using 16 Svedberg (S) ribosomal ribonucleic acid gene sequencing. The microbiome diversity index measures the diversity of microbial species in malnourished children's gut microbiota, comparing it to reference or control populations. Higher values indicate greater diversity, providing insights into malnutrition's impact on gut microbiota composition.

Secondary Outcome Measures

  1. Anthropometric Measurements [8 Weeks]

    Change in the mean weight-for-height/length z-score in children with complicated severe acute malnutrition who have been taking prebiotics supplementation for 8 weeks.

  2. Neurodevelopment Assessment [8 Weeks]

    Impact assessment of prebiotic supplementation on children's neurodevelopment using the Malawi Development Assessment tool

  3. Muscle mass accumulation [8 Weeks]

    The study investigates the impact of prebiotic consumption on body composition changes using the Body Stat Analyzer as a quantitative measurement tool.

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Months to 59 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Inclusion criteria: Age 6-59 months at enrolment;

  • Acute malnutrition without complications, as defined by the World Health Organization (i.e., children with mid-upper arm circumference (MUAC) <115 mm or weight-for-height z-score <-3 or grade 1-2 bilateral edema who will be clinically well and alert with good appetite);

  • Parental consent for the child to participate.

  • Healthy children without any chronic or acute illness

Exclusion Criteria:
  • Presence of any complications of severe malnutrition (severe dehydration, severe anemia, severe pitting edema, anorexia, hypothermia, high pyrexia, acute lower respiratory infection, or hypoglycemia) or immunocompromised.

  • Children on antibiotic treatment for any disease in the last 3 months will be excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Public Health, University of the Punjab Lahore Pakistan 54500

Sponsors and Collaborators

  • University of the Punjab
  • University of Veterinary and Animal Sciences, Lahore - Pakistan

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. Javeria Saleem, Assistant Professor, University of the Punjab
ClinicalTrials.gov Identifier:
NCT06155474
Other Study ID Numbers:
  • D/137/FIMS
First Posted:
Dec 4, 2023
Last Update Posted:
Dec 4, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr. Javeria Saleem, Assistant Professor, University of the Punjab
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 4, 2023